BioSpace News Archive

BioMidwest

SAB Biotherapeutics Launches Utah-Based Subsidiary SAB Capra, LLC.

SAb Biotherapeutics announced today they have formed and officially launched a Utah-based wholly owned subsidiary, SAB Capra, LLC and incorporated the new entity under the SAB Biotherapeutics corporate umbrella.

December 22, 2017

·

4 min read

Pharm Country

John Theurer Cancer Center Release: Pivotal CAR-T Therapy Cancer Study Published in the New England Journal of Medicine

John Theurer Cancer Center at Hackensack University Medical Center is the only New Jersey center that participated in a pivotal clinical trial of a groundbreaking cancer treatment, CAR-T Cell therapy, which genetically modifies a patient’s immune system to attack cancer cells.

December 22, 2017

·

5 min read

Orchard Therapeutics to Present at the 36th Annual J.P. Morgan Healthcare Conference

Orchard Therapeutics today announced that Mark Rothera, president and CEO, will present at the 36th Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Tuesday, January 9, 2018 at 3:00 p.m. PT.

December 22, 2017

·

1 min read

Pharm Country

Akers Bio Announces Closing of $6,900,000 Public Offering

The funds raised will be used for working capital, product development, marketing activities, expanding our internal sales organization and further developing sales channels and other capital expenditures.

December 22, 2017

·

4 min read

Pharm Country

Roswell Park Research Identifies Cells that May be Responsible for Prostate Cancer Recurrence

Although men with prostate cancer usually respond to standard treatment with hormone therapy or chemotherapy, many will eventually experience progression or recurrence despite treatment - particularly those with high-risk or aggressive forms of the disease.

December 22, 2017

·

2 min read

BioCapital

FDA Updates the Label of Tasigna to Reflect That Certain Patients With a Type of Leukemia May Bb Eligible to Stop Treatment After Sustained Response

The FDA today updated the product label for the cancer drug Tasigna to include information for providers about how to discontinue the drug in certain patients.

December 22, 2017

·

6 min read

BioMidwest

American Society of Mass Spectrometry in Indy

From June 4-8, the city of Indianapolis had the privilege of playing host to nearly 6500 scientists from around the world who gathered to discuss all aspects of using mass spectrometry in a wide variety of applications.

December 22, 2017

·

1 min read

Policy

QIAGEN to Take Impairment on Deferred Tax Assets, Informs on Expected Impacts of New U.S. Tax Law and Other Changes in Global Tax Environment

QIAGEN N.V.announces that, mainly as a consequence of the new U.S. tax legislation, it will take an after-tax charge on net income of approximately $110-120 million (or about $0.47-$0.52 per share) in the fourth quarter of 2017.

December 22, 2017

·

1 min read

Genetown

Bioverativ Announces 2018 Annual Meeting of Stockholders

Bioverativ announced today that its 2018 Annual Meeting of Stockholders has been scheduled for April 25, 2018.

December 22, 2017

·

1 min read